BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2009
View Archived Issues
Boehringer Ingelheim claims new oncolytic PI3K inhibitors in recent patent
Read More
New PAI-1 inhibitors claimed by Kowa for treating thrombotic disorders
Read More
Novel cannabinoid CB1 receptor antagonists discovered at Schering-Plough
Read More
Novo Nordisk reviews Q4 progress
Read More
iTherX to initiate proof-of-concept study for ITX-5061 in hepatitis C
Read More
Prasugrel receives approval recommendation from FDA Advisory Committee
Read More
Pfizer's Sutent is recommended as first-line treatment for kidney cancer
Read More
Allos reports results from pivotal pralatrexate trial in peripheral T-cell lymphoma
Read More
GSK and Theravance announce positive results from three fluticasone furoate trials
Read More
OncoGenex provides 2-year survival data from ongoing OGX-011 trial
Read More
Abraxis BioScience launches Abraxane in Germany
Read More
JMR-132, AN-162 demonstrate ovarian tumor growth inhibition in xenograft models
Read More
Alseres completes enrollment in Altropane POET-2 phase III program
Read More
Medivir selects MIV-710 as a candidate drug for osteoporosis and osteoarthritis
Read More
Novel T-type calcium channel inhibitors discovered by Merck & Co. researchers
Read More
Novel TNF-alpha production inhibitors reported by Daiichi Sankyo for treatment of sepsis
Read More
CyDex successfully completes phase II clinical trial of Captisol-Enabled nasal spray in SAR
Read More
Isoform-selective phospholipase D inhibitors developed at Vanderbilt University
Read More
Waiting period expires for MAP and AstraZeneca's agreement for budesonide
Read More
Warner Chilcott acquires NexMed's alprostadil for erectile dysfunction
Read More
Human ProIslet Peptide stimulates islet neogenesis
Read More
FDA approves Galderma's Vectical for mild to moderate plaque psoriasis
Read More
Peregrine announces results from phase II clinical trial of bavituximab in NSCLC
Read More
European Commission clears acquisition of Zentiva by sanofi-aventis
Read More
FDA Advisory Committee favors approval of DX-88 for hereditary angioedema
Read More